What is Gian Life Care share price return in the past 10 years?

Data is not available for this company

Gian Life Care Ltd - Stock Valuation and Financial Performance

Name: Gian Life Care
Brand: Gian Life Care

BSE: 542918 | NSE: | Hospital & Healthcare Services | Small Cap

Place order

Gian Life Care Share Price

₹16.10 -0.29 -1.77%
as on 28-Apr'25 09:41

DeciZen - make an informed investing decision on Gian Life Care

Based on:

Data

M-Cap below 100cr DeciZen not available

Gian Life Care stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

4.16

Market Cap:

17 Cr.

52-wk low:

12.1

52-wk high:

Is Gian Life Care Ltd an attractive stock to invest in?

1. Is Gian Life Care Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Gian Life Care Ltd is a good quality company.

2. Is Gian Life Care Ltd undervalued or overvalued?

The key valuation ratios of Gian Life Care Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.

3. Is Gian Life Care Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Gian Life Care Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Gian Life Care:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis ^P

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
ROCE % ⓘ	12.3%	42.5%	35.9%	53.2%	12.4%	29.2%	-
Value Creation Index ⓘ	-0.1	2.0	1.6	2.8	-0.1	1.1	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	0.6	7.7	10.5	15.9	11.9	13.1	12
Sales YoY Gr.	-	1,266.1%	36.7%	52.3%	-25.2%	10.1%	-
Adj EPS ⓘ	0.2	1.1	2	4.2	1.2	4.2	3.9
YoY Gr.	-	373.9%	78.9%	116.9%	-71.2%	240.2%	-
BVPS (₹) ⓘ	0.3	7.4	9.3	13.6	14.8	19	19.2
Adj Net Profit ⓘ	0.1	1.1	2	4.4	1.3	4.3	4
Cash Flow from Ops. ⓘ	3	1.5	2.9	5.8	2.3	0.8	-
Debt/CF from Ops. ⓘ	0.5	0.7	0.4	0.4	2	5.5	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	87.9%	7.9%	10.1%
Adj EPS ⓘ	NA	78.4%	28.6%	240.2%
BVPSⓘ	NA	137.7%	26.6%	28.1%
Share Price	-	21.8%	-16.1%	-20.5%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
Return on Equity % ⓘ	90.9	29.1	23.3	36.9	8.6	24.6	20.6
Op. Profit Mgn % ⓘ	35	30.3	33.3	43.5	17.1	47.3	47
Net Profit Mgn % ⓘ	18	14.7	19.3	27.5	10.5	32.7	33.1
Debt to Equity ⓘ	12.3	0.1	0.1	0.1	0.3	0.2	0.1
Working Cap Days ⓘ	0	291	321	281	496	545	244
Cash Conv. Cycle ⓘ	0	-13	-2	-47	-38	-177	68

Recent Performance Summary

Net Profit is growing at healthy rate in last 3 years 28.63%

Sales growth is good in last 4 quarters at 34.37%

Return on Equity has declined versus last 3 years average to 20.60%

Sales growth has been subdued in last 3 years 7.85%

Latest Financials - Gian Life Care Ltd.

	Standalone	Consolidated
TTM EPS (₹)	3.9	3.8
TTM Sales (₹ Cr.)	12.3	12.3
BVPS (₹.) ⓘ	19.2	18.8
Reserves (₹ Cr.) ⓘ	10	9
P/BV ⓘ	0.85	0.87
PE ⓘ	4.16	4.35

From the Market
52 Week Low / High (₹)	12.06 / 26.98
All Time Low / High (₹)	5.48 / 65.91
Market Cap (₹ Cr.)	17
Equity (₹ Cr.)	10.3
Face Value (₹)	10
Industry PE ⓘ	42.2

Quarterly Results

Standalone Basis

Consolidated Basis

	Mar'24	YoY Gr. Rt. %	Jun'24	YoY Gr. Rt. %	Sep'24	YoY Gr. Rt. %	Dec'24	YoY Gr. Rt. %
Sales (₹ Cr.)ⓘ	2,609	21.3	938	98.1	1,045	122.3	954	40.6
Adj EPS (₹) ⓘ	35.6	-8.7	8.5	29.5	9	41.2	10.8	82.8
Op. Profit Mgn % ⓘ	16.71	105 bps	10.80	112 bps	11.11	-79 bps	14.47	286 bps
Net Profit Mgn % ⓘ	9.12	-242 bps	7.50	-280 bps	6.98	-500 bps	8.36	-97 bps

Management X-Ray of Gian Life Care:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

26.53

0.00

62.27

* Pledged shares as % of Promoter's holding (%)

Valuation of Gian Life Care

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

No data found!

Key Ratios of Gian Life Care

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Peer Comparison

Company Name	CMP(₹)	Change ₹(%)	Market Cap	Net Sales (₹ Cr.)	Latest EPS (₹)	Net Profit Margin %	Latest P/E	Latest P/BV
Narayana Hrudayalay	1,817.2	29.8 (1.7%)	Small Cap	5,018	38.4	15.7	46.6	10.8
Aster DM Healthcare	508.1	2.8 (0.6%)	Small Cap	3,699	105.6	5.5	4.8	7.2
Dr. Lal Pathlabs	2,817.5	-89.1 (-3.1%)	Small Cap	1,967	59.5	19.5	48.9	11.4
Indraprastha Medical	410.5	7.6 (1.9%)	Small Cap	1,245	16.5	10	24.4	6.6
RainbowChildrenS Med	1,382.4	-13 (-0.9%)	Small Cap	1,237	23	17.4	60.7	9.9
Krishna Inst.Medi	671	-3.1 (-0.5%)	Small Cap	1,222	6.4	19.3	104.7	13
Kovai Medical Center	5,565.1	-30.5 (-0.6%)	Small Cap	1,220	188.7	14.8	29.7	5.9
Metropolis Health.	1,728.1	-23.6 (-1.3%)	Small Cap	1,208	29.7	11	59	7.4
HealthcareGlobal	561.9	3.7 (0.7%)	Small Cap	1,099	-0.8	3	-	6.6
Jupiter Life Line	1,470	-30.7 (-2%)	Small Cap	911	28	16.7	53.7	7.1

Shows rows:

Prev 1 2 3 4 5 Next

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Sales	0.56	7.65	10.46	15.93	11.92	13.12
Operating Expenses ⓘ	0.36	5.33	6.98	9	9.88	6.91
Manufacturing Costs	0.02	0.23	0.26	0.40	0.47	0.32
Material Costs	0.07	1.59	3.57	2.82	2.76	1.76
Employee Cost	0.11	1.02	0.94	1.31	1.58	0.91
Other Costs ⓘ	0.17	2.49	2.20	4.47	5.07	3.92
Operating Profit ⓘ	0.20	2.32	3.48	6.93	2.04	6.21
Operating Profit Margin (%)	35.0%	30.3%	33.3%	43.5%	17.1%	47.3%
Other Income ⓘ	0	0.10	0.29	0.51	0.69	0.64
Interest ⓘ	0.04	0.61	0.73	1.25	0.45	0.47
Depreciation ⓘ	0.02	0.26	0.29	0.33	0.50	0.46
Exceptional Items ⓘ	0	0	0	0	0	0
Profit Before Tax ⓘ	0.14	1.56	2.75	5.85	1.79	5.91
Tax ⓘ	0.04	0.43	0.74	1.48	0.53	1.62
Profit After Tax	0.10	1.13	2.02	4.37	1.26	4.30
PAT Margin (%)	18.0%	14.7%	19.3%	27.5%	10.5%	32.7%
Adjusted EPS (₹)	0.2	1.1	2.0	4.2	1.2	4.2
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Equity and Liabilities
Shareholders Fund	0.11	7.64	9.66	14.03	15.31	19.62
Share Capital ⓘ	0.01	4.70	4.70	10.34	10.34	10.34
Reserves ⓘ	0.10	2.94	4.96	3.69	4.97	9.27
Minority Interest	0	0	0	0	0	0
Debt	0.98	0.79	0.67	1.87	4.34	3.69
Long Term Debt	0.98	0.75	0.62	1.87	1.65	1.80
Short Term Debt	0	0.04	0.05	0	2.69	1.89
Trade Payables	1.01	1.11	1.63	1.55	2.87	3.07
Others Liabilities ⓘ	5.72	2.83	3.52	5.61	5.87	5.69
Total Liabilities ⓘ	7.82	12.37	15.48	23.06	28.40	32.07
Fixed Assets
Gross Block	2.93	3.12	3.55	4.38	6	6.31
Accumulated Depreciation	0.02	0.28	0.56	0.89	1.39	1.85
Net Fixed Assetsⓘ	2.91	2.84	2.99	3.50	4.62	4.47
CWIP ⓘ	0	0	0	0.12	0.14	0.14
Investmentsⓘ	0	0	0	0.11	0.11	0.11
Inventories	0.84	0.86	1.02	1.49	0.88	0.88
Trade Receivables	1.32	1.57	2.05	1.78	3.25	4.81
Cash Equivalents	1.10	1.13	2.51	4.74	5.75	5.97
Others Assetsⓘ	1.64	5.97	6.90	11.32	13.65	15.69
Total Assets ⓘ	7.82	12.37	15.48	23.06	28.40	32.07

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Cash Flow From Operating Activity ⓘ	2.99	1.51	2.87	5.79	2.32	0.75
PBT ⓘ	0.14	1.56	2.75	5.85	1.79	5.91
Adjustment ⓘ	0.04	0.60	0.42	1.93	0.26	0.28
Changes in Working Capital ⓘ	2.81	-0.42	-0.01	-1.32	0.3	-5.42
Tax Paid ⓘ	0	-0.23	-0.30	-0.67	-0.02	-0.02
Cash Flow From Investing Activity ⓘ	-2.92	-3.96	-1.10	-4.23	-0.94	0.33
Capex	-2.93	-0.19	-0.43	-0.96	-1.63	-0.31
Net Investments	0	0.07	0	-0.29	0	0
Others ⓘ	0	-3.85	-0.66	-2.99	0.69	0.64
Cash Flow From Financing Activityⓘ	0.96	2.55	-0.39	0.67	-0.37	-0.86
Net Proceeds from Shares ⓘ	0.01	3.11	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	-0.22	-0.25
Interest Paid ⓘ	-0.03	-0.30	-0.30	-0.35	-0.43	-0.45
Dividend Paid ⓘ	0	0	0	0	0	0
Others ⓘ	0.98	-0.26	-0.09	1.02	0.28	-0.16
Net Cash Flow ⓘ	1.03	0.10	1.38	2.23	1.01	0.22

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Ratios
ROE (%)	90.94	29.08	23.33	36.94	8.57	24.59
ROCE (%)	12.26	42.47	35.91	53.19	12.44	29.24
Asset Turnover Ratio	0.07	0.76	0.75	0.83	0.46	0.43
PAT to CFO Conversion(x)	29.9	1.34	1.42	1.32	1.84	0.17
Working Capital Days
Receivable Days	865	69	63	44	77	112
Inventory Days	549	41	33	29	36	25
Payable Days	5,575	244	140	206	292	615

Gian Life Care Ltd Stock News

View All News

Gian Life Care Ltd FAQs

What is the share price of Gian Life Care?

Company share prices are keep on changing according to the market conditions. The closing price of Gian Life Care on 28-Apr-2025 09:41 is ₹16.10.

What is the market cap of Gian Life Care?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 28-Apr-2025 09:41 the market cap of Gian Life Care stood at ₹16.95.

What is the P/E ratio of Gian Life Care?

The latest P/E ratio of Gian Life Care as of 28-Apr-2025 09:41 is 4.16.

What is the P/B ratio of Gian Life Care?

The latest P/B ratio of Gian Life Care as of 28-Apr-2025 09:41 is 0.85.

What is the 52-week high and low of Gian Life Care?

The 52-week high of Gian Life Care is ₹26.98 and the 52-week low is ₹12.06.

What is the TTM revenue of Gian Life Care?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Gian Life Care is ₹12.32 ( Cr.) .

About Gian Life Care Ltd

Gian Life Care was incorporated on November 06, 2018, under the provisions of the Companies Act, 2013 by Registrar of Companies, Kanpur. On March 01, 2019 the company took over the entire running business of Gian Pathology and X-Rays, a proprietorship concern of the promoter Arun Kumar Gupta with a view to provide diagnostic and related healthcare tests and services.

Business area of the Company:

The company is engaged in the business of providing diagnostic and related healthcare services. The company provides a wide range of diagnostic tests and services like patient diagnosis services, prevention, and wellness diagnosis services to patients and healthcare providers. The company caters to individual patients, hospitals, corporates and other healthcare providers. The company offers over 1,344 tests including biochemistry, clinical pathology, coagulation, cytogenetics, cytology, hematology, histopathology, immunoassay, microbiology, molecular biology, and radiology services. Gian Life is NABL accredited and ISO 9001:2015 certified company.

Key Events and Milestones:

2018: Incorporation of the Company in the name of ‘Gian Life Care Limited’
2019: Acquired the running business along with substantial assets and liabilities of Gian Pathology and X rays, proprietorship concern of the Promoter.